| Literature DB >> 26010909 |
Stephane Kremer1, Felix Renard2, Sophie Achard2, Marco A Lana-Peixoto3, Jacqueline Palace4, Nasrin Asgari5, Eric C Klawiter6, Silvia N Tenembaum7, Brenda Banwell8, Benjamin M Greenberg9, Jeffrey L Bennett10, Michael Levy11, Pablo Villoslada12, Albert Saiz12, Kazuo Fujihara13, Koon Ho Chan14, Sven Schippling15, Friedemann Paul16, Ho Jin Kim17, Jerome de Seze18, Jens T Wuerfel16, Philippe Cabre19, Romain Marignier20, Thomas Tedder21, Danielle van Pelt22, Simon Broadley23, Tanuja Chitnis6, Dean Wingerchuk24, Lekha Pandit25, Maria Isabel Leite4, Metha Apiwattanakul26, Ingo Kleiter27, Naraporn Prayoonwiwat28, May Han29, Kerstin Hellwig30, Katja van Herle31, Gareth John32, D Craig Hooper33, Ichiro Nakashima13, Douglas Sato13, Michael R Yeaman34, Emmanuelle Waubant35, Scott Zamvil35, Olaf Stüve9, Orhan Aktas36, Terry J Smith37, Anu Jacob38, Kevin O'Connor39.
Abstract
Brain parenchymal lesions are frequently observed on conventional magnetic resonance imaging (MRI) scans of patients with neuromyelitis optica (NMO) spectrum disorder, but the specific morphological and temporal patterns distinguishing them unequivocally from lesions caused by other disorders have not been identified. This literature review summarizes the literature on advanced quantitative imaging measures reported for patients with NMO spectrum disorder, including proton MR spectroscopy, diffusion tensor imaging, magnetization transfer imaging, quantitative MR volumetry, and ultrahigh-field strength MRI. It was undertaken to consider the advanced MRI techniques used for patients with NMO by different specialists in the field. Although quantitative measures such as proton MR spectroscopy or magnetization transfer imaging have not reproducibly revealed diffuse brain injury, preliminary data from diffusion-weighted imaging and brain tissue volumetry indicate greater white matter than gray matter degradation. These findings could be confirmed by ultrahigh-field MRI. The use of nonconventional MRI techniques may further our understanding of the pathogenic processes in NMO spectrum disorders and may help us identify the distinct radiographic features corresponding to specific phenotypic manifestations of this disease.Entities:
Mesh:
Year: 2015 PMID: 26010909 PMCID: PMC4828237 DOI: 10.1001/jamaneurol.2015.0248
Source DB: PubMed Journal: JAMA Neurol ISSN: 2168-6149 Impact factor: 18.302